First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial

Ying Cheng, Shuang Zhang, Liang Han, Lin Wu, Jun Chen, Peiyan Zhao, Hongmei Sun, Guilan Wen, Yinghua Ji, Anastasia Zimina, Jianhua Shi, Zhijie Pan, Jinsheng Shi, Xicheng Wang, Yuansong Bai, Tamar Melkadze, Yueyin Pan, Xuhong Min, Maksym Viguro, Xingya Li, Yanqiu Zhao, Junquan Yang, Tamta Makharadze, Ekaterine Arkania, Haoyu Yu, Jing Li, Fang Yang, Xinyi Yang, Chen Ling, Qingyu Wang, Yongqiang Shan, Jun Zhu, Unknown

Open source

DOI: 10.1002/cac2.70032
Published: 2025-05-29
Container: Cancer Communications
Publisher: American Association for the Advancement of Science (AAAS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cac2.70032,
  title = {First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial},
  author = {Ying Cheng and Shuang Zhang and Liang Han and Lin Wu and Jun Chen and Peiyan Zhao and Hongmei Sun and Guilan Wen and Yinghua Ji and Anastasia Zimina and Jianhua Shi and Zhijie Pan and Jinsheng Shi and Xicheng Wang and Yuansong Bai and Tamar Melkadze and Yueyin Pan and Xuhong Min and Maksym Viguro and Xingya Li and Yanqiu Zhao and Junquan Yang and Tamta Makharadze and Ekaterine Arkania and Haoyu Yu and Jing Li and Fang Yang and Xinyi Yang and Chen Ling and Qingyu Wang and Yongqiang Shan and Jun Zhu and Unknown},
  year = {2025},
  journal = {Cancer Communications},
  doi = {10.1002/cac2.70032},
  url = {https://doi.org/10.1002/cac2.70032}
}

RIS

TY  - JOUR
TI  - First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial
AU  - Ying Cheng
AU  - Shuang Zhang
AU  - Liang Han
AU  - Lin Wu
AU  - Jun Chen
AU  - Peiyan Zhao
AU  - Hongmei Sun
AU  - Guilan Wen
AU  - Yinghua Ji
AU  - Anastasia Zimina
AU  - Jianhua Shi
AU  - Zhijie Pan
AU  - Jinsheng Shi
AU  - Xicheng Wang
AU  - Yuansong Bai
AU  - Tamar Melkadze
AU  - Yueyin Pan
AU  - Xuhong Min
AU  - Maksym Viguro
AU  - Xingya Li
AU  - Yanqiu Zhao
AU  - Junquan Yang
AU  - Tamta Makharadze
AU  - Ekaterine Arkania
AU  - Haoyu Yu
AU  - Jing Li
AU  - Fang Yang
AU  - Xinyi Yang
AU  - Chen Ling
AU  - Qingyu Wang
AU  - Yongqiang Shan
AU  - Jun Zhu
AU  - Unknown
PY  - 2025
JO  - Cancer Communications
DO  - 10.1002/cac2.70032
UR  - https://doi.org/10.1002/cac2.70032
ER  -

APA

Cheng, Y., Zhang, S., Han, L., Wu, L., Chen, J., Zhao, P., Sun, H., Wen, G., Ji, Y., Zimina, A., Shi, J., Pan, Z., Shi, J., Wang, X., Bai, Y., Melkadze, T., Pan, Y., Min, X., Viguro, M., Li, X., Zhao, Y., Yang, J., Makharadze, T., Arkania, E., Yu, H., Li, J., Yang, F., Yang, X., Ling, C., Wang, Q., Shan, Y., Zhu, J., & Unknown (2025). First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial. Cancer Communications. https://doi.org/10.1002/cac2.70032

Source records

crossref · retrieved 2026-09-27T15:41:31.301Z